News by Tag: Cancer Vaccine Market
Global Leader in Cancer Vaccines: US Continues to Surge on Growth Path
January 9, 2013
US currently holds a 49% share in the global cancer vaccines market and continues to experience robust growth opportunities, says RNCOS.
January 9, 2013
US currently holds a 49% share in the global cancer vaccines market and continues to experience robust growth opportunities, says RNCOS.
Therapeutic Cancer Vaccines in Phase-3 Clinical Trials Influencing Market Dynamics
October 4, 2012
With 18 therapeutic cancer vaccine studies in phase-3 clinical trials, new entrants in the therapeutic cancer vaccines market can be expected in next 5 years.
October 4, 2012
With 18 therapeutic cancer vaccine studies in phase-3 clinical trials, new entrants in the therapeutic cancer vaccines market can be expected in next 5 years.
US: The Most Promising Market for Cancer Vaccines across the Globe
September 26, 2012
Accounting to a 49% share in the global cancer vaccines market, backed by huge investments, US represents a huge potential market for cancer vaccines, says RNCOS.
September 26, 2012
Accounting to a 49% share in the global cancer vaccines market, backed by huge investments, US represents a huge potential market for cancer vaccines, says RNCOS.